Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Naruse

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Tissue Antigens|May 1, 1997
Molecular genetic analysis of HLA class II alleles in Japanese patients with melanomaT Kageshita, T Naruse, S Hirai, et al.
Tissue Antigens|May 12, 2007
Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populationsA Kimura, M Takahashi, B Y Choi, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
HLA class I antigens in Japanese patients with melanomaT Kageshita, T Naruse, S Hirai, et al.
International Journal of Hematology|March 11, 1999
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study GroupM Yoshida, M Karasawa, T Naruse, et al.
Transplantation Proceedings|February 25, 1998
TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantationT Kobayashi, I Yokoyama, S Hayashi, et al.
The Journal of Dermatology|November 3, 1998
HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303A Ozawa, M Miyahara, J Sugai, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 24, 1998
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ]K Kitamura, H Hirai, N Hosoya, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Tissue Antigens|May 1, 1997
Molecular genetic analysis of HLA class II alleles in Japanese patients with melanomaT Kageshita, T Naruse, S Hirai, et al.
Tissue Antigens|May 12, 2007
Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populationsA Kimura, M Takahashi, B Y Choi, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
HLA class I antigens in Japanese patients with melanomaT Kageshita, T Naruse, S Hirai, et al.
International Journal of Hematology|March 11, 1999
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study GroupM Yoshida, M Karasawa, T Naruse, et al.
Transplantation Proceedings|February 25, 1998
TAP1, TAP2, LMP2, DMA, and DMB genetic polymorphisms in renal transplantationT Kobayashi, I Yokoyama, S Hayashi, et al.
The Journal of Dermatology|November 3, 1998
HLA class I and II alleles and susceptibility to generalized pustular psoriasis: significant associations with HLA-Cw1 and HLA-DQB1*0303A Ozawa, M Miyahara, J Sugai, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 24, 1998
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ]K Kitamura, H Hirai, N Hosoya, et al.
Pageof 31